Vitamin D and Cardiovascular Disease

被引:79
|
作者
Wang, Thomas J. [1 ]
机构
[1] Vanderbilt Univ, Med Ctr, Div Cardiovasc Med, Nashville, TN 37232 USA
来源
关键词
vitamin D; cardiovascular disease; prevention; RANDOMIZED CONTROLLED-TRIAL; SMOOTH-MUSCLE-CELLS; RENIN-ANGIOTENSIN SYSTEM; NEGATIVE ENDOCRINE REGULATOR; TYPE-2; DIABETIC-PATIENTS; CORONARY HEART-DISEASE; D-BINDING PROTEIN; D-RECEPTOR; BLOOD-PRESSURE; 1,25-DIHYDROXYVITAMIN D-3;
D O I
10.1146/annurev-med-051214-025146
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Vitamin D is best known for its influence on skeletal health. There is growing recognition, however, that vitamin D has nonskeletal actions, which could have important implications for understanding the consequences of vitamin D deficiency. In epidemiologic studies, vitamin D deficiency has been consistently associated with an increased risk for cardiovascular disease and hypertension. Disruption of vitamin D signaling in animal models promotes hypertension, cardiac hypertrophy, and atherosclerosis. This evidence has led to the initiation of prospective randomized trials of vitamin D supplementation in individuals at risk for cardiovascular disease. The results of these trials should help to guide strategies for screening and management of vitamin D deficiency in the clinic and at the population level.
引用
收藏
页码:261 / 272
页数:12
相关论文
共 50 条
  • [31] Vitamin D, cardiovascular disease and mortality
    Pilz, Stefan
    Tomaschitz, Andreas
    Maerz, Winfried
    Drechsler, Christiane
    Ritz, Eberhard
    Zittermann, Armin
    Cavalier, Etienne
    Pieber, Thomas R.
    Lappe, Joan M.
    Grant, William B.
    Holick, Michael F.
    Dekker, Jacqueline M.
    [J]. CLINICAL ENDOCRINOLOGY, 2011, 75 (05) : 575 - 584
  • [32] Vitamin D deficiency and cardiovascular disease
    Ahmed, Saeed
    Ratanapo, Supawat
    Kittanamongkolchai, Wonngarm
    Cheungpasitporn, Wisit
    Suksaranjit, Promporn
    Chongnarungsin, Daych
    [J]. SWISS MEDICAL WEEKLY, 2013, 143
  • [33] Vitamin D and cardiovascular disease prevention
    Pilz, Stefan
    Verheyen, Nicolas
    Gruebler, Martin R.
    Tomaschitz, Andreas
    Maerz, Winfried
    [J]. NATURE REVIEWS CARDIOLOGY, 2016, 13 (07) : 404 - 417
  • [34] Vitamin D and Atherosclerotic Cardiovascular Disease
    Hiemstra, Thomas F.
    Lim, Kenneth
    Thadhani, Ravi
    Manson, JoAnn E.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2019, 104 (09): : 4033 - 4050
  • [35] Vitamin D and cardiovascular disease risk
    Michos, Erin D.
    Melamed, Michal L.
    [J]. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2008, 11 (01): : 7 - 12
  • [36] Vitamin D and cardiovascular disease in chronic kidney disease
    Gurpreet Kaur
    Jatinder Singh
    Juhi Kumar
    [J]. Pediatric Nephrology, 2019, 34 : 2509 - 2522
  • [37] Vitamin D and cardiovascular disease in chronic kidney disease
    Kaur, Gurpreet
    Singh, Jatinder
    Kumar, Juhi
    [J]. PEDIATRIC NEPHROLOGY, 2019, 34 (12) : 2509 - 2522
  • [38] Vitamin D supplements and prevention of cardiovascular disease
    Orkaby, Ariela R.
    Djousse, Luc
    Manson, JoAnn E.
    [J]. CURRENT OPINION IN CARDIOLOGY, 2019, 34 (06) : 700 - 705
  • [39] THE IMPACT OF VITAMIN D ON CARDIOVASCULAR DISEASE, AND BEYOND
    Zittermann, Armin
    [J]. ANTICANCER RESEARCH, 2022, 42 (04) : 2214 - 2215
  • [40] Vitamin D and cardiovascular disease: Update and outlook
    Pilz, Stefan
    Kienreich, Katharina
    Tomaschitz, Andreas
    Lerchbaum, Elisabeth
    Meinitzer, Andreas
    Marz, Winfried
    Zittermann, Armin
    Dekker, Jacqueline M.
    [J]. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2012, 72 : 83 - 91